Blue toe syndrome, severe haemophilia A and emicizumab

Haemophilia. 2024 Jan;30(1):241-244. doi: 10.1111/hae.14893. Epub 2023 Oct 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Bispecific* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Blue Toe Syndrome*
  • Factor VIII
  • Hemophilia A* / drug therapy
  • Humans

Substances

  • emicizumab
  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • Factor VIII